PHASE-I STUDY OF CYCLOPHOSPHAMIDE (NSC26271) BY 72-HOUR CONTINUOUS INTRAVENOUS-INFUSION

被引：7
|
作者：
BEDIKIAN, AY [1 ]
BODEY, GP [1 ]
机构：
[1] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,DEPT DEV THERAPEUT,HOUSTON,TX 77030
来源：
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 1983年 / 6卷 / 03期
关键词：
D O I：
10.1097/00000421-198306000-00018
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：365 / 368
页数：4
相关论文
共 50 条
  • [1] PHASE-I STUDY OF BISANTRENE BY 72-HOUR INFUSION
    KOVACH, JS
    KVOLS, LK
    POWIS, G
    [J]. INVESTIGATIONAL NEW DRUGS, 1984, 2 (01) : 109 - 109
  • [2] A phase I study of rhizoxin (NSC 332598) by 72-hour continuous intravenous infusion in patients with advanced solid tumors
    Tolcher, AW
    Aylesworth, C
    Rizzo, J
    Izbicka, E
    Campbell, E
    Kuhn, J
    Weiss, G
    Von Hoff, DD
    Rowinsky, EK
    [J]. ANNALS OF ONCOLOGY, 2000, 11 (03) : 333 - 338
  • [3] PHASE-I STUDY OF DEOXYCYTIDINE ADMINISTERED AS A 120 HOUR CONTINUOUS INTRAVENOUS-INFUSION
    BHALLA, K
    GRANT, S
    MACLAUGHLIN, W
    COLE, J
    BIRKHOFER, M
    KAPPEL, B
    KRITZ, A
    GRAHAM, G
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 355 - 355
  • [4] A PHASE-I TRIAL OF ICRF-187 (NSC 169780) BY 48 HOUR CONTINUOUS INTRAVENOUS-INFUSION
    DAVIS, TE
    KOELLER, J
    DAVIS, HL
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 164 - 164
  • [5] CLEARANCE OF ETOPOSIDE DURING CONTINUOUS 72-HOUR INTRAVENOUS-INFUSION IN CHILDREN
    CROM, WR
    KALWINSKY, D
    GLYNN, AM
    EVANS, WE
    [J]. DRUG INTELLIGENCE & CLINICAL PHARMACY, 1986, 20 (06): : 472 - 472
  • [6] PHASE-I AND PHARMACOKINETIC STUDY OF MENOGARIL ADMINISTERED AS A 72-HOUR CONTINUOUS IV-INFUSION
    LONG, HJ
    POWIS, G
    SCHUTT, AJ
    MOERTEL, CG
    [J]. CANCER TREATMENT REPORTS, 1987, 71 (06): : 593 - 598
  • [7] PHASE-I STUDY OF ADOZELESIN ADMINISTERED BY 24-HOUR CONTINUOUS INTRAVENOUS-INFUSION
    FLEMING, GF
    RATAIN, MJ
    OBRIEN, SM
    SCHILSKY, RL
    HOFFMAN, PC
    RICHARDS, JM
    VOGELZANG, NJ
    KASUNIC, DA
    EARHART, RH
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (05) : 368 - 372
  • [8] PHASE-I CLINICAL AND PHARMACOLOGICAL STUDY OF 72-HOUR CONTINUOUS INFUSION OF ETOPOSIDE IN PATIENTS WITH ADVANCED CANCER
    BENNETT, CL
    SINKULE, JA
    SCHILSKY, RL
    SENEKJIAN, E
    CHOI, KE
    [J]. CANCER RESEARCH, 1987, 47 (07) : 1952 - 1956
  • [9] PHASE-I TRIAL AND PHARMACOKINETICS OF ACIVICIN ADMINISTERED BY 72-HOUR INFUSION
    EARHART, RH
    KOELLER, JM
    DAVIS, TE
    BORDEN, EC
    MCGOVREN, JP
    DAVIS, HL
    TORMEY, DC
    [J]. CANCER TREATMENT REPORTS, 1983, 67 (7-8): : 683 - 692
  • [10] BIOCHEMICAL ASSESSMENT OF THE EFFECTS OF ACIVICIN AND DIPYRIDAMOLE GIVEN AS A CONTINUOUS 72-HOUR INTRAVENOUS-INFUSION
    FISCHER, PH
    WILLSON, JKV
    RISUENO, C
    TUTSCH, K
    BRUGGINK, J
    RANHOSKY, A
    TRUMP, DL
    [J]. CANCER RESEARCH, 1988, 48 (19) : 5591 - 5596
12345